Hartmann’s Solution for Infusion, PPC PSEB bag
Authorisation PA2059/057/003 · Fresenius Kabi Deutschland GmbH
- Licence holder
- Fresenius Kabi Deutschland GmbH (all products →)
- Active substances
- Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Sodium lactate
- Clinical trials
- 3 clinical trials → 3 clinical trials → 2 clinical trials →
- Dosage form
- Solution for infusion
- Route of administration
- Intravenous use
- ATC codes
- B05BB, B05BB01
- First authorised
- 20/05/2005
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Sodium chloride: supply and approvals
126 authorised products on the HPRA list contain Sodium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- Sodium Acetate Injection: in shortage, updated 15 Nov 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Potassium chloride: supply and approvals
68 authorised products on the HPRA list contain Potassium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- Potassium Chloride Tablet, Extended Release: resolved, updated 21 Nov 2025
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Calcium chloride dihydrate: supply and approvals
55 authorised products on the HPRA list contain Calcium chloride dihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- 1 supply notice, e.g. OsvaRen (24 Mar 2025 to 31 Mar 2027)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 21 years (since 20 May 2005). The HPRA list marks it as marketed in Ireland.
Other medicines with Sodium chloride in Ireland
121 other products on the HPRA list contain Sodium chloride, from 22 licence holders; 76 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
Other medicines with Potassium chloride in Ireland
87 other products on the HPRA list contain Potassium chloride, from 23 licence holders; 56 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Accusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltration | Nikkiso Belgium bvba | National authorisation (PA) | Marketed |
| Accusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltration | Nikkiso Belgium bvba | National authorisation (PA) | Marketed |
| Celsior solution for organ preservation | Institut Georges Lopez - IGL | National authorisation (PA) | Marketed |
| Centyl K 2.5 mg/573 mg modified-release tablets | Karo Pharma AB | National authorisation (PA) | Marketed |
| Compound Sodium Lactate Intravenous Infusion BP, Solution for Infusion (Hartmann’s Solution) | B. Braun Melsungen AG | National authorisation (PA) | Marketed |
| Compound Sodium Lactate Solution for Infusion BP | Baxter Holding B.V. | National authorisation (PA) | Marketed |
| Dioralyte Blackcurrant Powder for Oral Solution | Phoenix Labs | National authorisation (PA) | Marketed |
| Dioralyte Citrus Powder for Oral Solution | Phoenix Labs | National authorisation (PA) | Marketed |
| Dioralyte Natural, Powder for oral solution | Phoenix Labs | National authorisation (PA) | Marketed |
| Finomel Emulsion for Infusion | Baxter Holding B.V. | National authorisation (PA) | Marketed |
| Finomel Peri Emulsion for Infusion | Baxter Holding B.V. | National authorisation (PA) | Marketed |
| Gelaspan Solution for Infusion | B. Braun Melsungen AG | National authorisation (PA) | Marketed |
Other substances in ATC group B05BB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 10 other active substances share the group B05BB with this product:
Glucose monohydrate (5) · Sodium acetate trihydrate (4) · Magnesium chloride hexahydrate (4) · Glucose (2) · Sodium gluconate (2) · Sodium lactate solution (1) · Sodium lactate solution 60% (1) · Calciumchloride dihydrate (1) · Sodium hydroxide (1) · Glucose anhydrous (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Fresenius Kabi Deutschland GmbH holds 164 products on the HPRA list, with 164 different active substances; 69 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.